Menu
Apply

Hyperparathyroidism

Status
Identified

Approved and Donation Ready

This fund has been developed in response to patients who have contacted PAF for help with their medication expenses and could not find help. While this fund has been fully designed and we are ready to provide needed support to these patient communities, this fund is not yet able to accept applications for assistance as we are still working to secure charitable donations that will allow us to open it.

If you, or someone you know, would like to contribute to this fund, please visit our Donors page for more information on how to provide critical support for patients in need.

Fund Type

Co-pay, Co-Insurance & Deductible

Maximum Award Level

$1,500 Per Year

Eligibility Requirements
  • Household Income Requirements 400% or less of Federal Poverty Guideline (FPG) (adjusted for Cost of Living Index (COLI) and number in household)
  • Insurance Requirements Medicare, Medicaid, or Military Benefits
  • Must reside and receive treatment in the United States.

About Hyperparathyroidism

Hyperparathyroidism occurs when there is an excess of parathyroid hormone (PTH) in the bloodstream due to overactivity of one or more of the body’s four parathyroid glands, the cause is often the result of a benign adenoma forming on a parathyroid gland. The parathyroid hormone helps maintain an appropriate balance of calcium in the bloodstream and in tissues that depend on calcium for proper functioning. Hyperparathyroidism can occur at any age, but is more common in people between age 50 and 60, and women are affected about three times as often as men.
There are two types of hyperparathyroidism, primary and secondary. Primary hyperparathyroidism occurs when one or more of the parathyroid glands are overactive causing an overproduction of the parathyroid hormone, resulting in high levels of calcium in the blood known as hypercalcemia.
Secondary hyperparathyroidism refers to the excessive secretion of parathyroid hormone by the parathyroid glands in response to hypocalcemia and associated hyperplasia of the glands, in an attempt to keep the calcium levels normal. This disorder is especially seen in patients with chronic kidney failure and vitamin D deficiency.
At younger ages, Primary hyperparathyroidism is often caused by a familial hyperparathyroidism syndrome, which usually causes several of the parathyroid glands to enlarge rather than a single gland to become enlarged.

Hyperparathyroidism Resources
Medication & Financial Assistance Resources
The Patient Advocate Foundation's (PAF) Co-Pay Relief (CPR) Program does not review the information contained on the website links provided for content, accuracy or completeness. Use of and access to this information is subject to the terms, limitations and conditions as outlined on the accessed websites. PAF Co-Pay Relief Program makes no representation as to the accuracy or any other aspect of the information contained on any website accessed from the CPR website, nor does PAF Co-Pay Relief Program necessarily endorse the website information provided. The information presented on the PAF Co-Pay Relief website is provided for general information only and is not intended as a substitute for medical care. Please talk with your healthcare provider about any information you acquire from this or any other website accessed through the PAF Co-Pay Relief program website.
Apply